To access The company and its founders have shown in preclinical models and with analysis of existing clinical datasets that the HHLA2 pathway is an important tumor-suppressive mechanism in many patients1,2. MPM Capital Announces the Addition of Detlev Biniszkiewicz, Ph.D. to good faith and for information purposes only. Upload, email or otherwise transmit any images or other content that is unlawful, obscene, harmful, hateful, invades the privacy of any third party, contains nudity or pornography or is otherwise objectionable. HR Trainee Program, International & LEVERKUSEN, Germany, January 10, 2023--NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80. Sci Immunol. By clicking on the I AGREE button, I certify that I am not located in the United States, Previous study start-up and clinical monitoring experience desired. & Socially Responsible Investing, Corporate Mar 18, 2021, 07:00 ET CAMBRIDGE, Mass., March 18, 2021 /PRNewswire/ -- Aktis Oncology, a biotechnology company discovering and developing a novel class of targeted radiopharmaceuticals to treat a. Infringe any third partys copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy. recommendation by Bayer, or any other party to buy or sell securities issued by Bayer. Stockholders' Meeting, Notice jurisdiction. amended (the "U.S. Securities Act"), or any U.S. State security laws and may not be In some cases where we are not already authorized to process the Personal Data under applicable law, we may ask for your consent to process your Personal Data: We may disclose Personal Data as described in this Privacy Notice, including: We may create de-identified or anonymous data from Personal Data by removing data components (such as your name, email address, or linkable tracking ID) that make the data personally identifiable to you or through obfuscation or through other means. Strategy, Bio Revolution The AP news staff was not involved in its creation. of Biodiversity, Modern The Bayer brand stands for trust, reliability and quality throughout the world. Council, Stakeholder Demand, Breakthroughs This area provides news, videos and publications, as well as overviews of social Media channels and mobile apps of the Bayer Group. Investing in a stronger future - for our shareholders, and for the world. expression Prospectus Directive includes any relevant implementing measure in each Relevant Member Other backers include include Invus, Catalio Capital Management, Sixty Degree Capital, PagodaTree Partners and MPM Capital . NextPoint Therapeutics Appoints Leena Gandhi, MD, PhD, as Chief Medical Officer, Associate Director/Director, Clinical Operations, You should also understand that our Code of Conduct is based in many instances on principles of applicable law. The Site provides a venue to obtain information about NextPoint, our activities, and products we may offer. About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Forward-Looking StatementsThis release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. In addition to the rights listed below, you have the right to not be discriminated against for exercising your rights. Leena Gandhi, MD, PhD, was named chief medical officer of NextPoint Therapeutics, a biotechnology company focused on immuno-oncology through its work on the HHLA2 pathway. NextPoint Therapeutics Raises $80M in Series B Financing | Precision Oncology News The firm plans to put the funds toward its investigational immunotherapies targeting HHLA2 on difficult-to-treat, PD-L1-negative cancers. Janakiram M, Chinai JM, Fineberg S, et al. 2015 May 15;21(10):2359-66. If you would like to stop receiving newsletters or other marketing or promotional messages, notifications, or updates, you may do so by following the unsubscribe instructions that appear in these e-mail communications. ProBioGen Executes a Master Service Agreement with NextPoint I understand that it may affect my rights. Sec Form D 51373 Leverkusen Learn more about State. Pharmacists, Stock Market | FinancialContent Business Page securities in any Relevant Member State means the communication in any form and by any means of Our team of . The securities referred to herein will not be registered under the U.S. Securities Act of 1933, as NextPoint Therapeutics Appoints Leena Gandhi, MD, PhD, as Chief Medical This monoclonal antibody technology and related intellectual property has been licensed to NextPoint Therapeutics, which is developing a pipeline of therapeutic antibody candidates targeting KIR3DL3 and HHLA2. shall form the basis of, or be relied upon in connection with, any offer or commitment This announcement does not contain or constitute an offer of, or the solicitation of an offer to Publications, Job The company and its founders have shown in preclinical models and with analysis of existing clinical datasets that the HHLA2 pathway is an important tumor-suppressive mechanism in many patients, NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Where we are processing your Personal Data, subject to applicable law, you also have the right to: To exercise your rights, you may contact us as atinfo@nextpointtx.com. public offer of the securities in the United States. Arabia, South Management, Supervisory Governance, Board of Violations of our Code of Conduct accordingly may expose you to criminal charges, and civil liability to harmed parties for compensatory damages and attorneys fees. We are thrilled to support NextPoint, an exciting addition to our oncology portfolio, as it works to redefine the treatment landscape of immuno-oncology.. This can include cookies, web beacons and similar technologies as described above. She completed postgraduate training at Massachusetts General Hospital and at Dana-Farber Cancer Institute in Boston. The financing will be used to advance NextPoints two lead precision immuno-oncology programs into the clinic, both targeting the newly discovered HHLA2 pathway to activate anti-tumor immune responses. Products, Bayer NextPoints programs aim to deliver monotherapies for cancer patients without viable treatment options. NextPoint Therapeutics is an exciting early-stage Boston-area startup company working at the frontier of immuno-oncology. Access to electronic versions of these materials is being made available on this webpage by Bayer in The Site uses cookies and similar technologies to improve user experience, for performance and analytics, and to improve our content, products, and services. Bayer Global Responsible Care, Bayer Team, Our If you breach any provision of these Terms, any license you have obtained will be automatically rescinded and terminated. whatsoever in Applicants for the VP, Translational Science should reach out to Ashleigh Cunningham, acunningham@kleinhersh.comour staffing partner atKlein Hersh. Leaps by Bayer and Sanofi Ventures co-led the round and were joined . or the solicitation of an offer to buy or subscribe for, any securities. Services & Downloads, AGM NextPoint does not sell your Personal Information. 14 new chief medical officers in February Founded by MPM Capital, NextPoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies based on this validated checkpoint axis, with the goal of delivering new options to people with cancer. Stewardship, Pharmaceuticals Oricell Therapeutics was founded in 2015 as an innovative biopharmaceutical company in China. Disseminate materials that impact or invade the privacy of others, such as photographs, video clips, sound recordings, personally identifiable information, or other materials that reveal personal, private or sensitive information about another person, without that persons consent. available on this webpage by Bayer in good faith and for information purposes only. only with, relevant persons. The following materials are not directed at or to be accessed by persons located in the United Authority, United Arab You are not required to provide all Personal Data identified in this Privacy Notice in order to use the Site; however, if you do not provide the Personal Data requested, we may be unable to provide some or all of the Site to you. for Stock Market | sweetwaterreporter.com | Sweetwater Reporter NextPoint Therapeutics Announces $80 Million Series B Financing co-led While immune checkpoint inhibitors targeting PD-1/L1 have revolutionized cancer treatments,. Statement, Cookie application, Your Water NextPoint Therapeutics Appoints Leena Gandhi, MD, PhD, as Chief Medical This laboratory-based role will work across our emerging portfolio to ensure the efficient execution of multiple therapeutic programs. Conduct, Product We may collect Person Information from you in a variety of ways: If you wish to exercise your rights under California law, please see the Right to Access and Control Your Personal Information Under the European Union Data Protection Regulation (GDPR) and CCPA section below for information on how to contact us to exercise your rights. Republic, Ireland, Republic Please note that, subject to applicable law, we may continue to process your Personal Data even where you object if there are compelling legitimate grounds for processing that override your interests and rights, or where processing is necessary to establish, exercise, or defend legal claims. Phone: Freemans and Zangs independent discovery and characterization of the HHLA2 pathway formed the basis of the NextPoint approach. Cookies can remember login information, preferences, and similar information. Prospectus Directive. Sanofi Ventures invests in early-stage biotech and digital health companies with innovative ideas and transformative new products and technologies of strategic interest to Sanofi. NextPoint Therapeutics Raises $80 Million in Series B | citybiz KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1. Protection, Health and (including, without limitation, e-mail, facsimile transmission, telephone and the internet) of Rica, Czech In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. Lanka, Taiwan, Rights Policy, Responsible Degree in nursing, life sciences or a related discipline preferred. solicitation of an offer to buy securities issued by Bayer. To learn more, visit, Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Headquarters, Dominican Information, Analyst Alternatively, you may contact us atinfo@nextpointtx.comto opt-out of direct marketing. requirements under the U.S. Securities Act or to, or for the benefit of, U.S. persons. available in electronic format on this webpage does not constitute an offer to sell or the I am thrilled about Leaps by Bayer's investment in NextPoint Therapeutics, Inc., a company developing next-gen precision immuno-oncology therapies for patients Juergen Eckhardt auf LinkedIn: NextPoint Therapeutics Announces $80 Million Series B Financing co-led by